β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

β-Secretase1 (BACE1) protein concentrations and rates of enzyme activity, analyzed in human bodily fluids, are promising candidate biological markers for guidance in clinical trials investigating BACE1 inhibitors to halt or delay the dysregulation of the amyloid-β pathway in Alzheimer’s disease (AD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hampel, Harald, Lista, Simone, Vanmechelen, Eugeen, Zetterberg, Henrik, Giorgi, Filippo Sean, Galgani, Alessandro, Blennow, Kaj, Caraci, Filippo, Das, Brati, Yan, Riqiang, Vergallo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566058/
https://www.ncbi.nlm.nih.gov/pubmed/33066807
http://dx.doi.org/10.1186/s13195-020-00686-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566058/
https://www.ncbi.nlm.nih.gov/pubmed/33066807
http://dx.doi.org/10.1186/s13195-020-00686-3

Ejemplares similares